A dissection of SARS‑CoV2 with clinical implications (Review)

Felician Stancioiu, Georgios Papadakis, Stelios Kteniadakis, Boris Izotov, Michael Coleman, Demetrios Spandidos, Aristidis Tsatsakis

Research output: Contribution to journalReview articlepeer-review


We are being confronted with the most consequential pandemic since the Spanish flu of 1918‑1920 to the extent that never before have 4 billion people quarantined simultaneously; to address this global challenge we bring to the forefront the options for medical treatment and summarize SARS‑CoV2 structure and functions, immune responses and known treatments. Based on literature and our own experience we propose new interventions, including the use of amiodarone, simvastatin, pioglitazone and curcumin. In mild infections (sore throat, cough) we advocate prompt local treatment for the naso‑pharynx (inhalations; aerosols; nebulizers); for moderate to severe infections we propose a tried‑and‑true treatment: the combination of arginine and ascorbate, administered orally or intravenously. The material is organized in three sections: i) Clinical aspects of COVID‑19; acute respiratory distress syndrome (ARDS); known treatments; ii) Structure and functions of SARS‑CoV2 and proposed antiviral drugs; iii) The combination of arginine‑ascorbate.
Original languageEnglish
Pages (from-to)489-508
Number of pages20
JournalInternational Journal of Molecular Medicine
Issue number2
Early online date10 Jun 2020
Publication statusPublished - 1 Aug 2020

Bibliographical note

© Stancioiu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.


Dive into the research topics of 'A dissection of SARS‑CoV2 with clinical implications (Review)'. Together they form a unique fingerprint.

Cite this